UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | V | W | Z
Number of items: 299.

A

Ahmed, O; Lentaigne, C; Wright, F; McAleese, D; Dangwa, F; Wechalekar, A; Hughes, D; ... McNamara, C; + view all (2010) CD56 EXPRESSION AND TREATMENT OUTCOME WITH BORTEZOMIB THERAPY IN PATIENTS WITH RELAPSED PLASMA CELL MYELOMA. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 582 - 583). FERRATA STORTI FOUNDATION Gold open access

Alpendurada, F; Carpenter, JP; Deac, M; Kirk, P; Walker, JM; Porter, JB; Banya, W; ... Pennell, DJ; + view all (2010) Relation of myocardial T2* to right ventricular function in thalassaemia major. European Heart Journal , 31 (13) pp. 1648-1654. 10.1093/eurheartj/ehq106.

Alpendurada, F; Carpenter, JP; Deac, M; Kirk, P; Walker, JM; Porter, JB; Banya, W; ... Pennell, DJ; + view all (2010) Relation of myocardial T2*to right ventricular function in thalassaemia major. EUR HEART J , 31 (13) 1648 - 1654. 10.1093/eurheartj/ehq106.

Andre, R; Schure, U; Magnusson, A; Lahiri, N; Smith, D; Lowdell, MW; Bates, G; ... Tabrizi, SJ; + view all (2010) MYELOID CELL FUNCTION IN MOUSE MODELS OF HUNTINGTON'S DISEASE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 A5-A6. 10.1136/jnnp.2010.222570.17.

Andre, R; Schure, U; Magnusson, A; Lahiri, N; Smith, D; Lowdell, MW; Bates, G; ... Tabrizi, SJ; + view all (2010) MYELOID CELL FUNCTION IN MOUSE MODELS OF HUNTINGTON'S DISEASE. In: (pp. A5-A6). BMJ PUBLISHING GROUP

Ang, AL; Shah, FT; Davis, BA; Thomas, A; Murugachandran, G; Kumuradevan, J; Garbowksi, MW; (2010) Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox Implications for Clinical Practice. In: BLOOD. (pp. 1724 - 1724). AMER SOC HEMATOLOGY

Ang, AL; Shah, FT; Davis, BA; Thomas, A; Murugachandran, G; Kumuradevan, J; Garbowksi, MW; (2010) Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice. In: BLOOD. (pp. 1724 - 1724). AMER SOC HEMATOLOGY

Ardeseina, KM; Qian, WD; Smith, P; Warden, J; Stevens, L; Pocock, CFE; Miall, F; ... Linch, DC; + view all (2010) An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a) A Preliminary Analysis. In: BLOOD. (pp. 5 - 5). AMER SOC HEMATOLOGY

Ashrafian, H; O'Flaherty, L; Adam, J; Steeples, V; Chung, YL; East, P; Vanharanta, S; ... Pollard, PJ; + view all (2010) Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis. CANCER RES , 70 (22) 9153 - 9165. 10.1158/0008-5472.CAN-10-1949.

Austin, S; Cohen, H; (2010) Antiphospholipid syndrome. Medicine , 38 (2) pp. 101-104. 10.1016/j.mpmed.2009.10.012.

Ayto, R; Baker, R; North, J; Reed, M; Mehta, A; Hughes, D; (2010) LYMPHOCYTE ABNORMALITIES WITHIN GAUCHER DISEASE MAY PREDISPOSE TO AN ELEVATED RISK OF HAEMATOLOGICAL MALIGNANCY. Presented at: 15th Annual Meeting of the European-Hematology-Association, Barcelona, SPAIN.

Ayto, RM; Hughes, DA; Jeevaratnam, P; Rolles, K; Burroughs, AK; Mistry, PK; Mehta, AB; (2010) Long-Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease. AM J TRANSPLANT , 10 (8) 1934 - 1939. 10.1111/j.1600-6143.2010.03168.x.

B

Bauersachs, R; Berkowitz, SD; Brenner, B; Buller, HR; Decousus, H; Gallus, AS; Lensing, AW; ... Schellong, S; + view all (2010) Oral Rivaroxaban for Symptomatic Venous Thromboembolism. NEW ENGLAND JOURNAL OF MEDICINE , 363 (26) pp. 2499-2510. 10.1056/NEJMoa1007903.

Bellisola, G; Della Peruta, M; Vezzalini, M; Moratti, E; Vaccari, L; Birarda, G; Piccinini, M; ... Sorio, C; + view all (2010) Tracking InfraRed signatures of drugs in cancer cells by Fourier Transform microspectroscopy. ANALYST , 135 (12) pp. 3077-3086. 10.1039/c0an00509f.

Benkhelifa-Ziyyat, S; Bucher, S; Zanta-Boussif, M-A; Pasquet, J; Danos, O; (2010) Changes in the accessibility of the HIV-1 Integrase C-terminus in the presence of cellular proteins. Retrovirology , 7 27-. 10.1186/1742-4690-7-27.

Berro, M; Mayor, NP; Maldonado-Torres, H; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, AA; (2010) Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. pp. 276-283.

Berro, M; Mayor, NP; Maldonado-Torres, H; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; (2010) Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. HAEMATOL-HEMATOL J , 95 (2) 276 - 283. 10.3324/haematol.2009.010835. Gold open access

Biegstraaten, M; Mengel, E; Marodi, L; Petakov, M; Niederau, C; Giraldo, P; Hughes, D; ... van Schaik, IN; + view all (2010) Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study. BRAIN , 133 pp. 2909-2919. 10.1093/brain/awq198.

Biegstraaten, M; Mengel, E; Marodi, L; Petakov, M; Niederau, C; Giraldo, P; Hughes, D; ... van Schaik, IN; + view all (2010) Polyneuropathy in Type 1 Gaucher disease: A two-year, multinational, prospective observational study. Presented at: 6th Annual World Symposium of the Lysosomal-Disease-Network, Miami, FL.

Binny, CJ; McIntosh, JH; Tuddenham, E; Waddington, S; Buckley, S; Thrasher, A; Gray, JT; ... Davidoff, A; + view all (2010) Assessing the Potential of Perinatal Gene Transfer Using Congenital Factor VII Deficiency as a Model System. In: BLOOD. (pp. 114 - 114). AMER SOC HEMATOLOGY

Binny, CJ; McIntosh, JH; Tuddenham, E; Waddington, S; Buckley, S; Thrasher, A; Gray, JT; ... Davidoff, A; + view all (2010) Assessing the Potential of Perinatal Gene Transfer Using Congenital Factor VII Deficiency as a Model System. In: BLOOD. (pp. 114 - 114). AMER SOC HEMATOLOGY

Bolli, N; Payne, EM; Grabher, C; Lee, J-S; Johnston, AB; Falini, B; Kanki, JP; (2010) Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. Blood , 115 (16) pp. 3329-3340. 10.1182/blood-2009-02-207225.

Booth, NJ; McQuaid, AJ; Sobande, T; Kissane, S; Agius, E; Jackson, SE; Salmon, M; ... Vulmanovic-Stejic, M; + view all (2010) Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol , 184 (8) pp. 4317-4326.

Branchini, BR; Ablamsky, DM; Davis, AL; Southworth, TL; Butler, B; Fan, F; Jathoul, AP; (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. ANAL BIOCHEM , 396 (2) 290 - 297. 10.1016/j.ab.2009.09.009.

Breckpot, K; Escors, D; Arce, F; Lopes, L; Karwacz, K; Van Lint, S; Keyaerts, M; (2010) HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7. J VIROL , 84 (11) 5627 - 5636. 10.1128/JVI.00014-10.

Breckpot, K; Escors, D; Arce, F; Lopes, L; Karwacz, K; Van Lint, S; Keyaerts, M; (2010) HIV-1 lentiviral vector immunogenicity is mediated by Toll-Like Receptor 3 (TLR3) and TLR7. Journal of Virology , 84 (11) pp. 5627-5636. 10.1128/JVI.00014-10.

Brooks, SP; Coccia, M; Tang, HR; Kanuga, N; Machesky, LM; Bailly, M; Cheetham, ME; (2010) The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology. HUM MOL GENET , 19 (12) 2421 - 2432. 10.1093/hmg/ddq125.

Brouns, R; Thijs, V; Eyskens, F; Van den Broeck, M; Belachew, S; Van Broeckhoven, C; Redondo, P; ... De Deyn, PP; + view all (2010) Belgian Fabry Study Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease. STROKE , 41 (5) pp. 863-868. 10.1161/STROKEAHA.110.579409.

Burnett, AK; Hills, RK; Green, C; Jenkinson, S; Koo, K; Patel, Y; Guy, C; ... Gale, RE; + view all (2010) The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. BLOOD , 115 (5) 948 - 956. 10.1182/blood-2009-08-236588.

C

Calleja-Agius, J; Jauniaux, E; Pizzey, A; Muttukrishna, S; (2010) Pro and Anti Inflammatory Cytokines in Early Pregnancy Loss. In: (Proceedings) 57th Annual Meeting of the Society-for-Gynecologic-Investigation. (pp. 323A-323A). SAGE PUBLICATIONS INC

Cappellini, MD; Beris, P; Brissot, P; Porter, JB; Taher, A; Peterson, P; Rudell, E; (2010) Iron Overload Diagnosis and Management Among Clinicians: International Survey Showing Gaps In Knowledge and Need for Continuing Educational Programs. In: BLOOD. (pp. 1060 - 1060). AMER SOC HEMATOLOGY

Cappellini, MD; Elalfy, M; El-Beshlawy, A; Kattamis, A; Chan, LL; Li, C; Lin, KH; ... Porter, J; + view all (2010) EFFICACY OF DEFERASIROX IN PATIENTS WITH THALASSAEMIA MAJOR IS NOT AFFECTED BY A HISTORY OF HEPATITIS B OR C. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 718 - 719). FERRATA STORTI FOUNDATION Gold open access

Cappellini, MD; Porter, J; El-Beshlawy, A; Li, CK; Seymour, JF; Elalfy, M; Gattermann, N; ... Kattamis, A; + view all (2010) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica , 95 (4) pp. 557-566. 10.3324/haematol.2009.014696.

Cappellini, MD; Porter, J; El-Beshlawy, A; Li, CK; Seymour, JF; Elalfy, M; Gattermann, N; ... EPIC Study Investigators, ; + view all (2010) Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. HAEMATOL-HEMATOL J , 95 (4) 557 - 566. 10.3324/haematol.2009.014696. Gold open access

Carpenter, B; Haque, T; Dimopolou, M; Atkinson, C; Roughton, M; Grace, S; Denovan, S; ... Chakraverty, R; + view all (2010) Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation. Transplantation , 90 (5) pp. 564-570.

Carpenter, B; Haque, T; Dimopoulou, M; Atkinson, C; Roughton, M; Grace, S; Denovan, S; ... Chakraverty, R; + view all (2010) Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation. TRANSPLANTATION , 90 (5) 564 - 570. 10.1097/TP.0b013e3181e7a3bf.

Carpenter, BJM; Dimopoulou, M; Grace, S; Denovan, S; Orti, G; Atkinson, C; Roughton, M; ... Chakraverty, R; + view all (2010) In vivo Campath-1h is associated with a high incidence of EBV viraemia but low risk of PTLD following allogeneic stem cell transplantation. In: BONE MARROW TRANSPLANTATION. (pp. S213 - S213). NATURE PUBLISHING GROUP

Carpenter, JP; Alpendurada, F; Deac, M; MacEira, A; Garbowski, M; Kirk, P; Walker, JM; ... Pennell, D; + view all (2010) Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload. Journal of Cardiovascular Magnetic Resonance , 12 (1) 10.1186/1532-429X-12-24.

Carpenter, JP; Alpendurada, F; Deac, M; Maceira, A; Garbowski, M; Kirk, P; Walker, JM; ... Pennell, DJ; + view all (2010) Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload. Journal of Cardiovascular Magnetic Resonance , 12 , Article 24. 10.1186/1532-429X-12-24. Green open access
file

Castleton, AZ; Brazma, D; Howard-Reeves, J; Chanalaris, A; Glanville, J; Nizetic, D; Chakraverty, R; (2010) Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukaemia. BRIT J HAEMATOL , 151 (3) 285 - 288. 10.1111/j.1365-2141.2010.08350.x.

Chakraverty, R; Orti, G; Roughton, M; Shen, J; Fielding, A; Kottaridis, P; Milligan, D; ... Mackinnon, S; + view all (2010) Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. BLOOD , 116 (16) 3080 - 3088. 10.1182/blood-2010-05-286856.

Chappert, P; Leboeuf, M; Rameau, P; Lalfer, M; Desbois, S; Liblau, RS; Danos, O; ... Gross, D-A; + view all (2010) Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion. Eur J Immunol , 40 (2) pp. 339-350. 10.1002/eji.200839107.

Chi, C; Pollard, D; Tuddenham, EGD; Kadir, RA; (2010) Menorrhagia in Adolescents with Inherited Bleeding Disorders. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY , 23 (4) pp. 215-222. 10.1016/j.jpag.2009.11.008.

Ciau-Uitz, A; Pinheiro, P; Gupta, R; Enver, T; Patient, R; (2010) Tel1/ETV6 Specifies Blood Stem Cells through the Agency of VEGF Signaling. DEVELOPMENTAL CELL , 18 (4) pp. 569-578. 10.1016/j.devcel.2010.02.009.

Ciau-Uitz, A; Pinheiro, P; Gupta, R; Enver, T; Patient, R; (2010) Tel1/ETV6 Specifies Blood Stem Cells through the Agency of VEGF Signaling. Developmental Cell , 18 (4) 569 - 578. 10.1016/j.devcel.2010.02.009.

Coelho, V; Krysov, S; Ghaemmaghami, AM; Emara, M; Potter, KN; Johnson, P; Packham, G; ... Stevenson, FK; + view all (2010) Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 107 (43) pp. 18587-18592. 10.1073/pnas.1009388107.

Cohen, H; (2010) Case studies in decision making: improving patient safety through interventions based on SHOT data. [Lecture]. Presented at: International consensus conference on risk-based decision making for blood safety, Toronto.

Cohen, H; (2010) Clinical use of prothrombin complex concentrate. [Lecture]. Presented at: Euroanaesthesia, Helsinki.

Cohen, H; (2010) Clinical use of prothrombin complex concentrate: case studies. [Lecture]. Presented at: British society for haematology annual scientific meeting, Edinburgh.

Cohen, H; (2010) Interactive session on new oral anticoagulants for atrial fibrillation. Presented at: British geriatrics society, BMA house, London.

Cohen, H; (2010) Quality and safety metrics in anticoagulation. [Lecture]. Presented at: Institute of healthcare management, London.

Cohen, H; (2010) SHOT 2009 data part 1. [Lecture]. Presented at: SHOT annual symposium, Manchester.

Cohen, H; Hills, J; O'Brien, P; (2010) Late obstetric complications in antiphospholipid syndrome. In: (Proceedings) 13th international congress on antiphospholipid antibodies.

Cohen, H; Machin, SJ; (2010) Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants? LUPUS , 19 (4) 486 - 491. 10.1177/0961203310361355.

Cohen, H; Tincani, A; Boffa, MC; (2010) Obstetric criteria for antiphospholipid syndrome. Presented at: 13th international congress on antiphospholipid antibodies: obstetric task force, Galveston.

Cooley, S; Weisdorf, DJ; Guethlein, LA; Klein, JP; Wang, T; Le, CT; Marsh, SGE; ... Miller, JS; + view all (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. pp. 2411-2419.

Cooley, S; Weisdorf, DJ; Guethlein, LA; Klein, JP; Wang, T; Le, CT; Marsh, SGE; ... Miller, JS; + view all (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. BLOOD , 116 (14) pp. 2411-2419. 10.1182/blood-2010-05-283051.

Craddock, C; Chakraverty, R; (2010) Stem Cell Transplantation. In: Postgraduate Haematology: Sixth Edition. (pp. 722-745).

Craddock, C; Nagra, S; Peniket, A; Brookes, C; Buckley, L; Nikolousis, E; Duncan, N; ... Russell, N; + view all (2010) Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. HAEMATOL-HEMATOL J , 95 (6) 989 - 995. 10.3324/haematol.2009.013920. Gold open access

D

Das Neves, R; Jones, NS; Andreu, L; Gupta, R; Enver, T; Iborra, FJ; (2010) Connecting variability in global transcription rate to mitochondrial variability. Plos Biology , 8 (12) , Article e1000560.. 10.1371/journal.pbio.1000560. Green open access
file

Della Peruta, M; Giagulli, C; Laudanna, C; Scarpa, A; Sorio, C; (2010) RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones. MOL CANCER , 9 , Article 61. 10.1186/1476-4598-9-61. Gold open access

Della Peruta, M; Martinelli, G; Moratti, E; Pintani, D; Vezzalini, M; Mafficini, A; Grafone, T; ... Sorio, C; + view all (2010) Protein Tyrosine Phosphatase Receptor Type gamma Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia. CANCER RESEARCH , 70 (21) pp. 8896-8906. 10.1158/0008-5472.CAN-10-0258.

Dignan, FL; Greenblatt, D; Cox, M; Shaw, BE; Scarisbrick, JJ; (2010) Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease. In: BLOOD. (pp. 1417 - 1417). AMER SOC HEMATOLOGY

Dignan, FL; Greenblatt, D; Cox, M; Shaw, BE; Scarisbrick, JJ; (2010) Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease. In: BLOOD. (pp. 1417 - 1417). AMER SOC HEMATOLOGY

Duarte, RF; Martin-Henao, G; D'Addio, A; Gayoso, J; Shaw, BE; Russell, NH; Lemoli, R; (2010) Predictability of stem cell mobilization following GCSF plus/minus plerixafor based on day 4 peripheral blood CD34+cell levels: basis for a pre-emptive model of plerixafor use in patients with lymphoma and myeloma who mobilize poorly. In: BONE MARROW TRANSPLANTATION. (pp. S323 - S323). NATURE PUBLISHING GROUP

das Neves, RP; Jones, NS; Andreu, L; Gupta, R; Enver, T; Iborra, FJ; (2010) Connecting Variability in Global Transcription Rate to Mitochondrial Variability. PLOS BIOL , 8 (12) , Article e1000560. 10.1371/journal.pbio.1000560. Green open access
file

de Beaucoudrey, L; Samarina, A; Bustamante, J; Cobat, A; Boisson-Dupuis, S; Feinberg, J; Al-Muhsen, S; ... Casanova, J-L; + view all (2010) Revisiting Human IL-12R beta 1 Deficiency A Survey of 141 Patients From 30 Countries. MEDICINE , 89 (6) pp. 381-402. 10.1097/MD.0b013e3181fdd832.

E

Ebrahim, H; Baker, R; Mehta, A; Hughes, D; (2010) A pilot study investigating pathophysiology of late-onset Anderson-Fabry disease using genetic and functional tools. In: JOURNAL OF MEDICAL GENETICS. (pp. S88 - S88). B M J PUBLISHING GROUP

Elliott, P; Pasquale, F; Quarta, G; Baker, R; Hughes, D; Mehta, A; (2010) Prevalence of anderson-fabry disease in patients with hypertrophic cardiomyopathy. european anderson-fabry disease survey (aces). Presented at: ESC Congress, Stockholm, SWEDEN.

Evangeli, M; Mughal, K; Porter, JB; (2010) WHICH PSYCHOSOCIAL FACTORS ARE RELATED TO CHELATION ADHERENCE IN THALASSEMIA? A SYSTEMATIC REVIEW. HEMOGLOBIN , 34 (3) 305 - 321. 10.3109/03630269.2010.485080.

Evans, P; Kayyali, R; Hider, RC; Eccleston, J; Porter, JB; (2010) Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. TRANSL RES , 156 (2) 55 - 67. 10.1016/j.trsl.2010.05.002.

Evans, PJ; Kayyali, R; Hider, RC; Davis, BA; Eccleston, J; Porter, JB; (2010) Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). WILEY-BLACKWELL PUBLISHING, INC

Evans, SO; Dignan, F; Shaw, BE; Davies, F; Smith, MA; Dearden, C; Matutes, E; ... Potter, MN; + view all (2010) Clinical and economic benefits of using pegfilgrastim post autologous stem cell transplant. In: BONE MARROW TRANSPLANTATION. (pp. S317 - S317). NATURE PUBLISHING GROUP

F

Fallah-Arani, F; Goold, H; Flutter, BR; Sivakumaran, J; Bennett, CL; Chakraverty, R; (2010) Distinct temporal and spatial roles for host conventional and Langerhans cells in the development of graft-versus-host injury. In: BONE MARROW TRANSPLANTATION. (pp. S15 - S15). NATURE PUBLISHING GROUP

Farren, T; Liu, FT; Stephens, C; Macey, M; Jenner, M; Prentice, A; Nathwani, A; (2010) Inter Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia - Evaluation of the Novel CD160FCA Assay. In: BLOOD. (pp. 1122 - 1123). AMER SOC HEMATOLOGY

Farren, T; Liu, FT; Stephens, C; Macey, M; Jenner, M; Prentice, A; Nathwani, A; (2010) Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia-7 Evaluation of the Novel CD160FCA Assay. In: BLOOD. (pp. 1122 - 1123). AMER SOC HEMATOLOGY

Ferrer, IR; Wagener, ME; Robertson, JM; Turner, AP; Araki, K; Ahmed, R; Kirk, AD; ... Ford, ML; + view all (2010) Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol , 185 (4) pp. 2004-2008. 10.4049/jimmunol.1001176.

Fielding, AK; (2010) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica , 95 (1) pp. 8-12. 10.3324/haematol.2009.015974. Gold open access

Fielding, AK; (2010) How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. BLOOD , 116 (18) 3409 - 3417. 10.1182/blood-2010-01-242750.

Fielding, AK; Buck, G; Lazarus, HM; Litzow, MR; Luger, S; Marks, DI; McMillan, A; ... Goldstone, AH; + view all (2010) Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial. In: BLOOD. (pp. 77 - 77). AMER SOC HEMATOLOGY

Flutter, B; Edwards, N; Fallah-Arani, F; Henderson, S; Chai, JG; Sivakumaran, S; Ghorashian, S; ... Chakraverty, R; + view all (2010) Nonhematopoietic antigen blocks memory programming of alloreactive CD8(+) T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. J CLIN INVEST , 120 (11) 3855 - 3868. 10.1172/JCI41446.

Flutter, BR; Fallah-Arani, F; Sivakumaran, S; Bennett, CL; Ghorashian, S; Freeman, G; Sykes, M; (2010) Failure to imprint donor CD8 memory and exhaustion may explain loss of GVT responses following donor leukocyte infusions. In: BONE MARROW TRANSPLANTATION. (pp. S16 - S16). NATURE PUBLISHING GROUP

Foukas, LC; Berenjeno, IM; Gray, A; Khwaja, A; Vanhaesebroeck, B; (2010) Activity of any class IA PI3K isoform can sustain cell proliferation and survival. P NATL ACAD SCI USA , 107 (25) 11381 - 11386. 10.1073/pnas.0906461107.

Freeman, S; Hills, R; Virgo, P; Couzens, S; Lowdell, MW; McNamara, CJ; White, P; (2010) Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively. In: BLOOD. (pp. 1118 - 1119). AMER SOC HEMATOLOGY

Freeman, S; Hills, R; Virgo, P; Couzens, S; Lowdell, MW; McNamara, CJ; White, P; (2010) Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively. In: BLOOD. (pp. 1118 - 1119). AMER SOC HEMATOLOGY

G

Garbowski, MW; Porter, JB; (2010) Trends in myocardial haemosiderosis relate to vitamin D status in transfusionally iron overloaded patients. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 96 - 96). WILEY-BLACKWELL PUBLISHING, INC

Gardiner, C; Hills, J; Longhair, I; Machin, S; Cohen, H; (2010) How many tests do we need to diagnose antiphospholipid syndrome? In:

Gatt, A; Riddell, A; Calvaruso, V; Tuddenham, EG; Makris, M; Burroughs, AK; (2010) Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost , 8 (9) pp. 1994-2000. 10.1111/j.1538-7836.2010.03937.x.

Gattermann, N; Finelli, C; Della Porta, M; Fenaux, P; Ganser, A; Guerci-Bresler, A; Schmid, M; ... Rose, C; + view all (2010) Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. LEUKEMIA RESEARCH , 34 (9) pp. 1143-1150. 10.1016/j.leukres.2010.03.009.

Georgiadis, A; Tschernutter, M; Bainbridge, JW; Robbie, SJ; McIntosh, J; Nathwani, AC; Smith, AJ; (2010) AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins. Gene Ther. , 17 (4) pp. 486-493. 10.1038/gt.2009.162.

Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Robbie, SJ; McIntosh, J; Nathwani, AC; Smith, AJ; (2010) AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins. GENE THER , 17 (4) 486 - 493. 10.1038/gt.2009.162.

Ghorashian, S; Wright, G; Thomas, S; Hart, D; King, J; Voisine, C; Pospori, C; ... Stauss, H; + view all (2010) Optimising adoptive T cell therapy following allogeneic hematopoietic stem cell transplanation. In: Reisner, Y and Martelli, M, (eds.) Bone Marrow Transplantation Across Major Genetic Barriers. World scientific Publishing

Ghorashian, S; Wright, G; Thomas, S; Hart, DP; King, J; Voisine, C; Pospori, C; ... Stauss, HJ; + view all (2010) Optimising adoptive t cell therapy following allogeneic hematopoietic stem cell transplantation. In: Bone Marrow Transplantation Across Major Genetic Barriers. (pp. 1-492).

Giest, S; Grace, S; Senegaglia, AC; Pasquini, R; Gonzalo-Daganzo, RM; Fernandez, MN; Mackinnon, S; ... Travers, PJ; + view all (2010) Cytomegalovirus-specific CD8+T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies. BRIT J HAEMATOL , 148 (2) 311 - 322. 10.1111/j.1365-2141.2009.07969.x.

Gisselbrecht, C; Glass, B; Mounier, N; Gill, DS; Linch, DC; Trneny, M; Bosly, A; ... Schmitz, N; + view all (2010) Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era. JOURNAL OF CLINICAL ONCOLOGY , 28 (27) 4184 - 4190. 10.1200/JCO.2010.28.1618.

Goldberg, AD; Banaszynski, LA; Noh, KM; Lewis, PW; Elsaesser, SJ; Stadler, S; Dewell, S; ... Allis, CD; + view all (2010) Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions. CELL , 140 (5) 678 - 691. 10.1016/j.cell.2010.01.003.

Gomez, K; Tuddenham, EG; Mcvey, JH; (2010) Normal Haemostasis. In: Postgraduate Haematology: Sixth Edition. (pp. 746-771).

Green, CL; Evans, CM; Hills, R; Zhao, L; Burnett, A; Linch, DC; Gale, R; (2010) Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2 R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2 R172 or IDH1 Mutations. In: BLOOD. (pp. 50 - 50). AMER SOC HEMATOLOGY

Green, CL; Evans, CM; Hills, R; Zhao, L; Burnett, A; Linch, DC; Gale, R; (2010) Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2-R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2-R172 or IDH1 Mutations. In: BLOOD. (pp. 50 - 50). AMER SOC HEMATOLOGY

Green, CL; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2010) The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukaemia is dependent on FLT3/ITD status. BRITISH JOURNAL OF HAEMATOLOGY , 149 17 - 17.

Green, CL; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2010) The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status. BLOOD , 116 (15) 2779 - 2782. 10.1182/blood-2010-02-270926.

Green, CL; Koo, KK; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2010) Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations. J CLIN ONCOL , 28 (16) 2739 - 2747. 10.1200/JCO.2009.26.2501.

Green, L; Lawrie, AS; Patel, S; Hossain, F; Chitolie, A; Mackie, IJ; Haddad, FS; (2010) The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation. BRIT J HAEMATOL , 151 (5) 469 - 476. 10.1111/j.1365-2141.2010.08433.x.

Green, L; Lawrie, AS; Patel, S; Hossain, FS; Mackie, IJ; Haddad, F; Machin, SJ; (2010) Lower doses of prothrombin complex concentrate achieve emergency reversal of warfarin. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). WILEY-BLACKWELL PUBLISHING, INC

Green, L; Lawrie, AS; Patel, S; Hossain, FS; Mackie, IJ; Haddad, F; Machin, SJ; (2010) A comparison of rivaroxaban and fragmin prophylaxis after high risk orthopaedic surgery on thrombin generation test. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). WILEY-BLACKWELL PUBLISHING, INC

H

Hanley, J; Rastegarlari, G; Nathwani, AC; (2010) An introduction to induced pluripotent stem cells. BRIT J HAEMATOL , 151 (1) 16 - 24. 10.1111/j.1365-2141.2010.08296.x.

Haque, S; Di Meglio, P; Kassen, D; Clop, A; Nestle, F; Hayday, AC; (2010) Studies of HLA-C expression and regulation using BAC transgenic mice. In: IMMUNOLOGY. (pp. 139 - 139). WILEY-BLACKWELL PUBLISHING, INC

Hasleton, J; Pasquale, F; Garbowski, M; Walker, MJ; Porter, JB; Moon, JC; (2010) Superior Vena Cava Occlusion by Cardiovascular Magnetic Resonance. CIRCULATION , 122 (8) 853 - 853. 10.1161/CIRCULATIONAHA.110.948471.

Heslop, HE; Slobod, KS; Pule, MA; Hale, GA; Rousseau, A; Smith, CA; Bollard, CM; ... Rooney, CM; + view all (2010) Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. BLOOD , 115 (5) pp. 925-935. 10.1182/blood-2009-08-239186.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; ... Pocock, CFE; + view all (2010) Rituximab Plus Chlorambucil In Patients with CD20-Positive B Cell Chronic Lymphocytic Leukemia (CLL) Final Response Analysis of An Open Label Phase H Study. In: BLOOD. (pp. 307 - 307). AMER SOC HEMATOLOGY

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; ... Pocock, CFE; + view all (2010) Rituximab Plus Chlorambucil In Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukemia (CLL): Final Response Analysis of An Open-Label Phase II Study. In: BLOOD. (pp. 307 - 307). AMER SOC HEMATOLOGY

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; Oscier, D; ... Pocock, C; + view all (2010) An open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL): On behalf of the NCRI CLL sub-group. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Hollak, CEM; Aerts, JMFG; Belmatoug, N; Bembi, B; Bodamer, O; Cappellini, D; Collin-Histed, T; ... Zimran, A; + view all (2010) Guidelines for the restart of imiglucerase in patients with Gaucher disease: Recommendations from the European Working Group on Gaucher disease. BLOOD CELLS MOLECULES AND DISEASES , 44 (2) pp. 86-87. 10.1016/j.bcmd.2009.12.002.

Hughes, D; Adera, M; Castelli, J; Bragat, A; Marsden, DL; Boudes, PB; (2010) PRELIMINARY LONG-TERM SAFETY, TOLERABILITY, AND ASSESSMENTS OF RENAL FUNCTION OF ADULT FABRY PATIENTS RECEIVING TREATMENT WITH AT1001 (MIGALASTAT HYDROCHLORIDE), A PHARMACOLOGICAL CHAPERONE, FOR UP TO 3 YEARS. J INHERIT METAB DIS , 33 S148 - S148.

Hughes, D; Malmenas, M; (2010) A predictive severity score for Fabry disease. In: MOLECULAR GENETICS AND METABOLISM. (pp. S21 - S21). ACADEMIC PRESS INC ELSEVIER SCIENCE

Hughes, DA; Pastores, GM; (2010) The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approaches. Wien Med Wochenschr , 160 (23-24) pp. 594-599. 10.1007/s10354-010-0864-4.

Hughes, DA; Ramaswami, U; Barba Romero, M-A; Deegan, P; (2010) Age adjusting severity scores for Anderson-Fabry Disease. MOLECULAR GENETICS AND METABOLISM , 101 (2-3) pp. 219-227. 10.1016/j.ymgme.2010.06.002.

I

Illingworth, C; Pirmadjid, N; Serhal, P; Howe, K; FitzHarris, G; (2010) MCAK regulates chromosome alignment but is not necessary for preventing aneuploidy in mouse oocyte meiosis I. DEVELOPMENT , 137 (13) 2133 - 2138. 10.1242/dev.048306.

K

Karp, DR; Marthandan, N; Marsh, SGE; Ahn, C; Arnett, FC; DeLuca, DS; Diehl, AD; ... Scheuermann, RH; + view all (2010) Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. HUMAN MOLECULAR GENETICS , 19 (4) pp. 707-719. 10.1093/hmg/ddp521.

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2010) The Effect of Myeloma Cells on Bone Homeostasis Is Heterogenous and Correlates with Underlying Genetic Lesions and Bone Disease In Vivo. In: BLOOD. (pp. 1652 - 1652). AMER SOC HEMATOLOGY

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2010) The Effect of Myeloma Cells on Bone Homeostasis Is Heterogenous and Correlates with Underlying Genetic Lesions and Bone Disease In Vivo. In: BLOOD. (pp. 1652 - 1652). AMER SOC HEMATOLOGY

Kistler, AD; Mischak, H; Breunig, F; Hughes, DA; Barbey, F; Wuthrich, RP; Serra, AL; (2010) Identification of biomarkers for Fabry disease by urine proteomics. INT J CLIN PHARM TH , 48 S62 - S62.

Knight, A; Arnouk, H; Britt, W; Gillespie, GY; Lowdell, MW; Cloud, GA; Markert, JM; ... Lamb, LS; + view all (2010) V delta 1+gamma delta T cells are cytotoxic against glioblastoma multiforme. In: AMER ASSOC CANCER RESEARCH

Knight, A; Mackinnon, S; Lowdell, MW; (2010) CMV Reactive gamma/delta T Cells Are Equivalent to Their alpha/beta Counterparts In the Lysis of CMV Infected Targets - Potential for Post Transplant Adoptive Immunotherapy. In: BLOOD. (pp. 547 - 547). AMER SOC HEMATOLOGY

Knight, A; Mackinnon, S; Lowdell, MW; (2010) CMV-Reactive gamma/delta T Cells Are Equivalent to Their alpha/beta Counterparts In the Lysis of CMV-Infected Targets - Potential for Post Transplant Adoptive Immunotherapy. In: BLOOD. (pp. 547 - 547). AMER SOC HEMATOLOGY

Knight, A; Madrigal, AJ; Grace, S; Sivakumaran, J; Kottaridis, P; Mackinnon, S; Travers, PJ; (2010) The role of V delta 2-negative gamma delta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. BLOOD , 116 (12) 2164 - 2172. 10.1182/blood-2010-01-255166.

Kong, X-F; Vogt, G; Chapgier, A; Lamaze, C; Bustamante, J; Prando, C; Fortin, A; ... Casanova, J-L; + view all (2010) A novel form of cell type-specific partial IFN-gamma R1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. HUMAN MOLECULAR GENETICS , 19 (3) pp. 434-444. 10.1093/hmg/ddp507.

Kottaridis, PD; North, J; Marden, C; Grace, S; Jide-Banwo, S; Sivakumaran, J; Lowdell, MW; (2010) Human NK cells primed by a tumour cell line can be safely transplanted to haploidentical patients with AML and lead to demonstrable GvL activity and long-term NK chimerism. In: BONE MARROW TRANSPLANTATION. (pp. S67 - S68). NATURE PUBLISHING GROUP

Krysov, S; Potter, KN; Mockridge, CI; Coelho, V; Wheatley, I; Packham, G; Stevenson, FK; (2010) Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. BLOOD , 115 (21) pp. 4198-4205. 10.1182/blood-2009-12-254847.

Kyriakou, C; Canals, C; Cornelissen, JJ; Socié, G; Willemze, R; Ifrah, N; Greinix, HT; ... Schmitz, N; + view all (2010) Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol , 28 (33) pp. 4926-4934. 10.1200/JCO.2009.27.3607.

Kyriakou, C; Canals, C; Sibon, D; Cahn, JY; Kazmi, M; Arcese, W; Kolbe, K; ... Schmitz, N; + view all (2010) High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol , 28 (13) pp. 2227-2232. 10.1200/JCO.2009.24.4905.

L

Lal, A; Sweeters, N; Ng, V; Foote, D; Evans, P; Neumayr, L; Kurio, G; ... Vichinsky, E; + view all (2010) Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion Dependent Thalassemia. In: BLOOD. (pp. 1732 - 1733). AMER SOC HEMATOLOGY

Lal, A; Sweeters, N; Ng, V; Foote, D; Evans, P; Neumayr, L; Kurio, G; ... Vichinsky, E; + view all (2010) Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia. In: BLOOD. (pp. 1732 - 1733). AMER SOC HEMATOLOGY

Lambert, JR; Bomanji, JB; Peggs, KS; Thomson, KJ; Chakraverty, RK; Fielding, AK; Kottaridis, PD; ... Mackinnon, S; + view all (2010) Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. BLOOD , 115 (14) 2763 - 2768. 10.1182/blood-2009-11-255182.

Landmeier, S; Altvater, B; Pscherer, S; Meltzer, J; Sebire, N; Pule, M; Vera, J; ... Rossig, C; + view all (2010) Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo. LEUKEMIA , 24 (5) 1080 - 1084. 10.1038/leu.2010.38.

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Machin, SJ; Peyvandi, F; Scully, MA; (2010) The haemostatic impact of prion reduction in solvent detergent treated plasma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 64 - 65). WILEY-BLACKWELL PUBLISHING, INC

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) THE EFFECT OF PRION REDUCTION IN SOLVENT DETERGENT TREATED PLASMA ON HAEMOSTATIC VARIABLES. VOX SANG , 99 235 - 235.

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. VOX SANG , 99 (3) 232 - 238. 10.1111/j.1423-0410.2010.01346.x.

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. Vox Sang , 99 (3) pp. 232-238. 10.1111/j.1423-0410.2010.01346.x.

Lawrie, AS; Green, L; Mackie, IJ; Liesner, R; Machin, SJ; Peyvandi, F; (2010) Factor XIII - an under diagnosed deficiency - are we using the right assays? J THROMB HAEMOST , 8 (11) 2478 - 2482. 10.1111/j.1538-7836.2010.04028.x.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2010) Acquired factor XIII deficiency - an under investigated disorder. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Lawrie, AS; Mackie, IJ; Peyvandi, F; Machin, SJ; Peyvandi, F; Scully, MA; (2010) Evaluation of an automated platelet-based assay of von Willebrand ristocetin cofactor activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 33 - 33). WILEY-BLACKWELL PUBLISHING, INC

Lee, JW; Yoon, SS; Shen, ZXA; Ganser, A; Hsu, HC; Habr, D; Domokos, G; ... Epic Study Investigators, ; + view all (2010) Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. BLOOD , 116 (14) 2448 - 2454. 10.1182/blood-2010-01-261289.

Lee, L; Ahmed, SO; Symeonidis, A; Linch, DC; Goldstone, A; Chakraverty, R; Mackinnon, S; (2010) Cardiac toxicity in patients over the age of 60 undergoing autologous stem cell transplantation for lymphoma. In: BONE MARROW TRANSPLANTATION. (pp. S101 - S101). NATURE PUBLISHING GROUP

Lhériteau, E; Libeau, L; Mendes-Madeira, A; Deschamps, J-Y; Weber, M; Le Meur, G; Provost, N; ... Rolling, F; + view all (2010) Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors. Mol Ther , 18 (6) pp. 1085-1093. 10.1038/mt.2010.46.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; Cunningham, D; ... Trneny, M; + view all (2010) Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients < 65 years with poor prognosis histologically aggressive NHL. BRIT J HAEMATOL , 149 (2) 237 - 243. 10.1111/j.1365-2141.2010.08081.x.

Little, AM; Marsh, SG; Madrigal, JA; (2010) Histocompatibility. In: Postgraduate Haematology: Sixth Edition. (pp. 710-721).

Longair, I; Hills, J; Gardiner, C; Cohen, H; (2010) Clinical significance of differences between INR methods in over-anticoagulated patients. In: (Proceedings) 50th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 40-41). WILEY-BLACKWELL PUBLISHING, INC

Lrrzow, MR; Buck, G; Dewald, G; Fielding, A; Ketterling, R; Lazarus, HM; Luger, S; ... Goldstone, AH; + view all (2010) Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. pp. 232-233). AMER SOC HEMATOLOGY

M

Machin, SJ; Briggs, C; (2010) Mean platelet volume: a quick, easy determinant of thrombotic risk? JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 8 (1) pp. 146-147. 10.1111/j.1538-7836.2009.03673.x.

Mackinnon, S; Lambert, J; Bomanji, J; Peggs, K; Thomson, K; Chakraverty, R; Fielding, A; ... Ell, P; + view all (2010) Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplant for lymphoma. In: BONE MARROW TRANSPLANTATION. (pp. S285 - S285). NATURE PUBLISHING GROUP

Maiers, M; Bakker, JNA; Bochtler, W; Eberhard, H-P; Marsh, SGE; Mueller, C; Rist, H-G; (2010) Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products. BONE MARROW TRANSPLANTATION , 45 (5) pp. 839-842. 10.1038/bmt.2010.29.

Majumder, B; Lowdell, M; Gallimore, R; Lachman, H; Coghlan, JG; Shiu, MF; Rakhit, RD; (2010) Positive Correlation of Intracoronary C-Reactive Protein With Platelet-Monocyte Complexes and Serum Amyloid A Protein Suggests Local Interrelationship Between Platelet Activation and Inflammation in the Acute Coronary Syndrome Patients. In: LIPPINCOTT WILLIAMS & WILKINS

Majumder, B; Lowdell, M; Sapsford, R; Hurst, J; Coghlan, JG; Shiu, MF; Rakhit, R; (2010) Tissue factor expression by platelet bound monocytes correlates with intracoronary inflammation in ST elevation myocardial infarction patients. In: (Proceedings) ESC Congress. (pp. p. 977). OXFORD UNIV PRESS

Marazzi, MG; Chapgier, A; Defilippi, A-C; Pistoia, V; Mangini, S; Savioli, C; Dell'Acqua, A; ... Casanova, J-L; + view all (2010) Disseminated Mycobacterium scrofulaceum infection in a child with interferon-gamma receptor 1 deficiency. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , 14 (2) E167-E170. 10.1016/j.ijid.2009.03.025.

Marin, V; Pizzitola, I; Agostoni, V; Pule, M; Rousseau, R; Lawson, A; Finney, H; ... Biagi, E; + view all (2010) CYTOKINE INDUCED KILLER (CIK) CELLS FOR CELL THERAPY OF ACUTE MYELOID LEUKEMIA (AML): IMPROVEMENT OF IMMUNE ACTIVITY BY EXPRESSION OF CD33-SPECIFIC CHIMERIC RECEPTORS (CAR). HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 95 p. 305. Gold open access

Marsh, SGE; (2010) HLA Nomenclature. In: The HLA Complex in Biology and Medicine. (pp. 79-85). Jaypee Brothers: India.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update April 2010. HUMAN IMMUNOLOGY , 71 (10) pp. 1043-1050. 10.1016/j.humimm.2010.07.014.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update April 2010. TISSUE ANTIGENS , 76 (6) pp. 501-508. 10.1111/j.1399-0039.2010.01551.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update August 2009. TISSUE ANTIGENS , 75 (1) pp. 98-101. 10.1111/j.1399-0039.2009.01402.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update December 2009. TISSUE ANTIGENS , 76 (1) pp. 81-85. 10.1111/j.1399-0039.2010.01462.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update February 2010. TISSUE ANTIGENS , 76 (2) pp. 165-170. 10.1111/j.1399-0039.2010.01508.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update January 2010. TISSUE ANTIGENS , 76 (2) pp. 161-164. 10.1111/j.1399-0039.2010.01507.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update July 2009. TISSUE ANTIGENS , 75 (1) pp. 90-97. 10.1111/j.1399-0039.2009.01403.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update June 2010. HUMAN IMMUNOLOGY , 71 (10) pp. 1055-1059. 10.1016/j.humimm.2010.07.016.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update June 2010. TISSUE ANTIGENS , 76 (6) pp. 514-518. 10.1111/j.1399-0039.2010.01553.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update May 2010. HUMAN IMMUNOLOGY , 71 (10) pp. 1051-1054. 10.1016/j.humimm.2010.07.015.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update May 2010. TISSUE ANTIGENS , 76 (6) pp. 509-513. 10.1111/j.1399-0039.2010.01552.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update November 2009. TISSUE ANTIGENS , 76 (1) pp. 76-80. 10.1111/j.1399-0039.2010.01452.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update October 2009. TISSUE ANTIGENS , 75 (6) pp. 741-746. 10.1111/j.1399-0039.2010.01453.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update September 2009. TISSUE ANTIGENS , 75 (2) pp. 189-196. 10.1111/j.1399-0039.2009.01408.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Fernandez-Vina, M; ... Trowsdale, J; + view all (2010) Nomenclature for factors of the HLA system, 2010. TISSUE ANTIGENS , 75 (4) pp. 291-455. 10.1111/j.1399-0039.2010.01466.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Fernandez-Vina, M; ... Trowsdale, J; + view all (2010) An update to HLA Nomenclature, 2010. BONE MARROW TRANSPLANTATION , 45 (5) pp. 846-848. 10.1038/bmt.2010.79.

Martins, I; Kepp, O; Galluzzi, L; Senovilla, L; Schlemmer, F; Adjemian, S; Menger, L; ... Kroemer, G; + view all (2010) Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Ann N Y Acad Sci , 1209 pp. 77-82. 10.1111/j.1749-6632.2010.05740.x.

Mattar, CN; Nathwani, AC; Dighe, N; Waddington, S; McIntosh, J; Biswas, A; Fisk, N; ... Chan, J; + view all (2010) Late-Gestation Intravascular Delivery of Self-Complementary AAV Leads to Sustained Transgene Expression with the Possibility of Vector Integration Events in the Liver. In: HUMAN GENE THERAPY. (pp. 499 - 499). MARY ANN LIEBERT INC

Mayor, NP; Shaw, BE; Maldonado-Torres, H; Cooke, L; Madrigal, A; Marsh, SGE; (2010) Estimation of NOD2/CARD15 haplotypes and their impact on unrelated donor stem cell transplant outcome. In: TISSUE ANTIGENS. (pp. 556 - 557). WILEY-BLACKWELL PUBLISHING, INC

Mayor, NP; Shaw, BE; Maldonado-Torres, H; Cooke, L; Madrigal, JA; Marsh, SGE; (2010) Estimation of NOD2/CARD15 Haplotypes and Their Impact on the Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Leukemia. In: BLOOD. (pp. 982 - 983). AMER SOC HEMATOLOGY

McDonald, V; Mackie, IJ; Machin, SJ; Scully, MA; (2010) Anti-ADAMTS13 IgG antibody subclasses in thrombotic thrombocytopenic purpura and changes with rituximab therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McDonald, V; Manns, K; Mackie, IJ; Machin, SJ; Scully, MA; (2010) Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J THROMB HAEMOST , 8 (6) 1201 - 1208. 10.1111/j.1538-7836.2010.03818.x.

McGee, MC; Hamner, JB; Williams, RF; Rosati, SF; Sims, TL; Ng, CY; Gaber, MW; ... Davidoff, AM; + view all (2010) IMPROVED INTRATUMORAL OXYGENATION THROUGH VASCULAR NORMALIZATION INCREASES GLIOMA SENSITIVITY TO IONIZING RADIATION. INT J RADIAT ONCOL , 76 (5) 1537 - 1545. 10.1016/j.ijrobp.2009.12.010.

McIntosh, J; Lenting, PJ; Tuddenham, E; Sotannde, M; Waddington, S; Gray, JT; Davidoff, A; (2010) Stable High Level Coagulation Factor VIII Expression In Vivo Following Gene Transfer Using a Novel Expression Cassette Encoding a More Potent FVIII Variant. In: BLOOD. (pp. 115 - 115). AMER SOC HEMATOLOGY

McIntosh, J; Lenting, PJ; Tuddenham, E; Sotannde, M; Waddington, S; Gray, JT; Davidoff, A; (2010) Stable High Level Coagulation Factor VIII Expression In Vivo Following Gene Transfer Using a Novel Expression Cassette Encoding a More Potent FVIII Variant. In: BLOOD. (pp. 115 - 115). AMER SOC HEMATOLOGY

McWhinnie, AJ; Holman, R; Fowles, F; Casanova, AA; Shah, A; Wallis-Jones, S; Stevens, S; ... Marsh, SGE; + view all (2010) Saliva specimens collected with Oragene one are a reliable alternative to blood and buccal swabs for large scale DNA extraction and HLA typing of recruits for hematopoietic stem cell donor registries. In: (Proceedings) 24th European Immunogenetics and Histocompatibility Conference/17th Annual Meeting of the Italian-Society-for-Immunogenetics-and-Transplantation-Biology. (pp. p. 547). WILEY-BLACKWELL PUBLISHING, INC

Mead, A; Thomson, KJ; Morris, EC; Mohamedbhai, S; Orti, G; Chakraverty, R; Linch, DC; ... Peggs, KS; + view all (2010) HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced intensity conditioning. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 21 - 21). WILEY-BLACKWELL PUBLISHING, INC

Mead, AJ; Thomson, KJ; Morris, EC; Mohamedbhai, S; Denovan, S; Orti, G; Fielding, AK; ... Peggs, KS; + view all (2010) HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. BLOOD , 115 (25) 5147 - 5153. 10.1182/blood-2010-01-265413.

Mednick, L; Yu, SL; Trachtenberg, F; Xu, Y; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; ... Thalassemia Clinical Res Network, ; + view all (2010) Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort. AM J HEMATOL , 85 (10) 802 - 805. 10.1002/ajh.21826.

Mehta, A; Hughes, D; Schneider, E; Dinh, Q; (2010) A Phase2 clinical trial to assess the safety and tolerability of the pharmacological chaperone AT 2101 in treatment-nave adult patients with type I Gaucher disease. Presented at: 6th Annual World Symposium of the Lysosomal-Disease-Network, Miami, FL.

Milligan, A; Hughes, D; Brooks, L; Goodwin, S; Jennings, A; Ajoku, U; Pringle, S; ... Mehta, A; + view all (2010) Agalsidase alfa and agalsidase beta in Fabry disease - our experience of reported infusion reactions over a 9-year period. Presented at: UNSPECIFIED.

Missiaglia, E; Dalai, I; Barbi, S; Beghelli, S; Falconi, M; della Peruta, M; Piemonti, L; ... Scarpa, A; + view all (2010) Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway. J CLIN ONCOL , 28 (2) 245 - 255. 10.1200/JCO.2008.21.5988.

Mold, DR; Jones, H; (2010) Development of a new web based haemovigilance data capture system for SHOT. In: (Proceedings) British society for haematology annual scientific meeting.

Morris, EC; Martinez-Davila, I; Cellerai, C; Chen, F; Moss, P; Khwaja, A; Virchis, A; ... Stauss, HJ; + view all (2010) WT1 peptide vaccination in poor risk adult AML patients induces WT1-specific immune responses: Results of a leukaemia research supported phase I clinical trial, WTPV-001. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 16 - 16). WILEY-BLACKWELL PUBLISHING, INC

N

Nathwani, A; (2010) Haemophilia B gene therapy study in the UK. HAEMOPHILIA , 16 (6) 973 - 973.

Nathwani, A; Tuddenham, E; Rosales, C; McIntosh, J; Riddell, A; Rustagi, P; Glader, B; ... Davidoff, A; + view all (2010) Early Clinical Trial Results Following Administration of a Low Dose of a Novel Self Complementary Adeno Associated Viral Vector Encoding Human Factor IX In Two Subjects with Severe Hemophilia B. In: BLOOD. (pp. 114 - 114). AMER SOC HEMATOLOGY

Nathwani, A; Tuddenham, E; Rosales, C; McIntosh, J; Riddell, A; Rustagi, P; Glader, B; ... Davidoff, A; + view all (2010) Early Clinical Trial Results Following Administration of a Low Dose of a Novel Self Complementary Adeno-Associated Viral Vector Encoding Human Factor IX In Two Subjects with Severe Hemophilia B. In: BLOOD. (pp. 114 - 114). AMER SOC HEMATOLOGY

Nathwani, AC; Tuddenham, EGD; Rosales, C; McIntosh, J; Riddell, A; Rustagi, P; Galder, B; ... Davidoff, AM; + view all (2010) Early clinical trial results following administration of a low dose of a novel self complementary adenohyphen;associated viral vector encoding human factor ix in two subjects with severe Haemophilia B. In: HUMAN GENE THERAPY. (pp. 1362 - 1362). MARY ANN LIEBERT INC

Nikolousis, E; Nagra, S; Ward, J; Dignan, FL; Shaw, BE; Littlewood, S; Byrne, J; ... Craddock, C; + view all (2010) Reduced Intensity Allogeneic Tranplants Are Well Tolerated In Patients Over the Age of 60: Identification of Factors Predicting Overall Survival. In: BLOOD. (pp. 976 - 977). AMER SOC HEMATOLOGY

O

Orti, G; Peggs, K; Collin, M; Clark, R; Milligan, D; Roddie, H; Liakopoulou, E; ... UK Collaborative Grp, ; + view all (2010) Final results of UK multi-centre, phase II study of Campath-1h dose de-escalation prior to non-myeloablative hla-identical sibling stem cell transplantation. In: BONE MARROW TRANSPLANTATION. (pp. S55 - S55). NATURE PUBLISHING GROUP

P

Pastores, GM; Hughes, DA; (2010) Editorial overview: lysosomal storage disorders with primary neurological involvement. JOURNAL OF INHERITED METABOLIC DISEASE , 33 (4) pp. 311-312. 10.1007/s10545-010-9147-x.

Patel, B; Rai, L; Buck, G; Richards, SM; Mortuza, Y; Mitchell, W; Gerrard, G; ... Foroni, L; + view all (2010) Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993. BRIT J HAEMATOL , 148 (1) 80 - 89. 10.1111/j.1365-2141.2009.07941.x.

Peggs, KS; Quezada, SA; (2010) Ipilimumab attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma. EXPERT REV ANTICANC , 10 (11) 1697 - 1701. 10.1586/ERA.10.144.

Peggs, KS; Thomson, K; Morris, E; Kottaridis, P; Hough, R; Goldstone, A; Fielding, A; ... Mackinnon, S; + view all (2010) Donor lymphocyte infusions guided by PET-CT offer durable salvage in relapsed Hodgkin's lymphoma post-allogeneic transplantation. In: BONE MARROW TRANSPLANTATION. (pp. S42 - S42). NATURE PUBLISHING GROUP

Peitsidis, P; Datta, T; Pafilis, I; Otomewo, O; Tuddenham, EGD; Kadir, RA; (2010) Bernard Soulier syndrome in pregnancy: a systematic review. HAEMOPHILIA , 16 (4) pp. 584-591. 10.1111/j.1365-2516.2009.02137.x.

Pennell, D; Porter, J; Cappellini, M; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2010) CONTINUED IMPROVEMENT IN CARDIAC T2*WITH DEFERASIROX TREATMENT OVER 2 YEARS: RESULTS FROM THE EXTENSION OF EPIC CARDIAC SUBSTUDY IN BETA-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 202 - 203). FERRATA STORTI FOUNDATION Gold open access

Pennell, D; Porter, J; Cappellini, M; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2010) DEFERASIROX EFFECTIVELY REMOVES CARDIAC IRON IN beta-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS PREVIOUSLY CHELATED WITH DEFEROXAMINE MONOTHERAPY OR DEFEROXAMINE-DEFERIPRONE THERAPY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 699 - 699). FERRATA STORTI FOUNDATION Gold open access

Pennell, D; Porter, JB; Cappellini, MD; Chan, LL; El Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2010) Continued Improvement and Normalization of Myocardial T2*In Patients with beta thalassemia Major Treated with Deferasirox (Exjade((R))) for up to 3 Years. In: BLOOD. (pp. 1735 - 1736). AMER SOC HEMATOLOGY

Pennell, D; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2010) Continued Improvement and Normalization of Myocardial T2*In Patients with beta-thalassemia Major Treated With Deferasirox (Exjade (R)) for up to 3 Years. In: BLOOD. (pp. 1735 - 1736). AMER SOC HEMATOLOGY

Pennell, DJ; Porter, JB; Cappellini, MD; El-Beshlawy, A; Chan, LL; Aydinok, Y; Elalfy, MS; ... Taher, A; + view all (2010) Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. BLOOD , 115 (12) 2364 - 2371. 10.1182/blood-2009-04-217455.

Pennell, DJ; Porter, JB; Cappellini, MD; El-Beshlawy, A; Chan, LL; Aydinok, Y; Elalfy, MS; ... Taher, A; + view all (2010) Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia. Blood , 115 (12) pp. 2364-2371. 10.1182/blood-2009-04-217455.

Perry, DJ; Fitzmaurice, DA; Kitchen, S; Mackie, IJ; Mallett, S; (2010) Point-of-care testing in haemostasis. BRIT J HAEMATOL , 150 (5) 501 - 514. 10.1111/j.1365-2141.2010.08223.x.

Peyvandi, F; Palla, R; Lotta, LA; Mackie, I; Scully, MA; Machin, SJ; (2010) ADAMTS-13 assays in thrombotic thrombocytopenic purpura. J THROMB HAEMOST , 8 (4) 631 - 640. 10.1111/j.1538-7836.2010.03761.x.

Philip, B; Thomas, S; Marin, V; Jathoul, A; Kopec, A; Linch, DC; Pule, M; (2010) A Highly Compact Epitope-Based Marker Suicide Gene for More Convenient and Safer T Cell Adoptive Immunotherapy. In: BLOOD. (pp. 629 - 630). AMER SOC HEMATOLOGY

Porakishvili, N; Lydyard, P; Bremser, A; Vispute, K; Memon, A; Kulikova, N; Clarke, E; ... Chiorazzi, N; + view all (2010) B Cell Chronic Lymphocytic Leukemia (B CLL) Cells Unresponsive to CD180 Ligation Fail to Respond to Anti IgM Stimulation as Well. In: BLOOD. (pp. 1475 - 1475). AMER SOC HEMATOLOGY

Porakishvili, N; Lydyard, P; Bremser, A; Vispute, K; Memon, A; Kulikova, N; Clarke, E; ... Chiorazzi, N; + view all (2010) B-Cell Chronic Lymphocytic Leukemia (B-CLL) Cells Unresponsive to CD180 Ligation Fail to Respond to Anti-IgM Stimulation as Well. In: BLOOD. (pp. 1475 - 1475). AMER SOC HEMATOLOGY

Porter, DL; Alyea, EP; Antin, JH; DeLima, M; Estey, E; Falkenburg, JHF; Hardy, N; ... van Besien, K; + view all (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. BIOL BLOOD MARROW TR , 16 (11) 1467 - 1503. 10.1016/j.bbmt.2010.08.001.

Porter, J; Elalfy, M; Aydinok, Y; Chan, LL; Lee, SH; Sutcharitchan, P; Taher, A; ... El-Beshlawy, A; + view all (2010) CORRELATIONS OF SERUM FERRITIN (SF) AND LIVER IRON CONCENTRATION (LIC) BEFORE AND AFTER 1 YEAR OF DEFERASIROX TREATMENT. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 708 - 709). FERRATA STORTI FOUNDATION Gold open access

Porter, J; Elalfy, M; Aydinok, Y; Chan, LL; Lee, SH; Sutcharitchan, P; Taher, A; ... El-Beshlawy, A; + view all (2010) EFFICACY AND SAFETY OF DEFERASIROX IN PATIENTS WITH BASELINE LIVER IRON CONCENTRATION (LIC) < 7 OR=7 MG FE/G DW: RESULTS OF EPIC LIVER MAGNETIC RESONANCE IMAGING (MRI) SUBSTUDY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 705 - 706). FERRATA STORTI FOUNDATION Gold open access

Porter, JB; (2010) Deferasirox-current knowledge and future challenges. COOLEY'S ANEMIA: NINTH SYMPOSIUM , 1202 87 - 93. 10.1111/j.1749-6632.2010.05582.x.

Porter, JB; Shah, FT; (2010) Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies. HEMATOL ONCOL CLIN N , 24 (6) 1109 - +. 10.1016/j.hoc.2010.08.015.

Prando, C; Boisson-Dupuis, S; Grant, AV; Kong, X-F; Bustamante, J; Feinberg, J; Chapgier, A; ... Casanova, J-L; + view all (2010) Paternal Uniparental Isodisomy of Chromosome 6 Causing a Complex Syndrome Including Complete IFN-gamma Receptor 1 Deficiency. AMERICAN JOURNAL OF MEDICAL GENETICS PART A , 152A (3) pp. 622-629. 10.1002/ajmg.a.33291.

Prokopowicz, ZM; Arce, F; Biedron, R; Chiang, CLL; Ciszek, M; Katz, DR; Nowakowska, M; ... Chain, BM; + view all (2010) Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive Immunity. J IMMUNOL , 184 (2) 824 - 835. 10.4049/jimmunol.0902606.

Pyo, C-W; Guethlein, LA; Vu, Q; Wang, R; Abi-Rached, L; Norman, PJ; Marsh, SGE; ... Geraghty, DE; + view all (2010) Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus. PLOS ONE , 5 (12) 10.1371/journal.pone.0015115. Gold open access

Q

Quezada, SA; Simpson, TR; Peggs, KS; Merghoub, T; Vider, J; Fan, XZ; Blasberg, R; ... Allison, JP; + view all (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J EXP MED , 207 (3) 637 - 650. 10.1084/jem.20091918.

Quinn, J; Glassford, J; Percy, L; Munson, P; Marafioti, T; Rodriguez-Justo, M; Yong, K; (2010) APRIL promotes cell cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. Blood

Quinn, J; Percy, L; Glassford, J; Somana, K; Rodriguez-Justo, M; Yong, K; (2010) CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous disease. British Journal of Haematology , 149 (1) 156 - 159.

R

Rai, L; Casanova, A; Moorman, AV; Richards, S; Buck, G; Goldstone, AH; Fielding, AK; (2010) Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study. BRITISH JOURNAL OF HAEMATOLOGY , 148 (3) pp. 394-401. 10.1111/j.1365-2141.2009.07966.x.

Rai, LJ; Dey, A; Patel, B; Fielding, AK; (2010) Minimal residual disease monitoring in adult acute lymphoblastic leukaemia in the UK; a multi-centre laboratory feasibility study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 43 - 43). WILEY-BLACKWELL PUBLISHING, INC

Richardson, S; Vandenberghe, E; Benjamin, R; Sudak, J; Goldstone, A; Thomson, K; Morris, E; ... Chakraverty, R; + view all (2010) Reduced-intensity allografting with in vivo T-cell depletion is associated with a favourable outcome in chronic lymphocytic leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S238 - S238). NATURE PUBLISHING GROUP

Richardson, SE, ; Sudak, J; Warbey, V; Ramsay, A; McNamara, C; (2010) A BONE MARROW BIOPSY IS NOT NECESSARY IN THE STAGING OF HODGKIN LYMPHOMA (HL) PATIENTS IN THE FDG-PET ERA. In: (Proceedings) 8th International Symposium of Hodgkin Lymphoma. (pp. S39-S40).

Rienhoff, HY; Viprakasit, V; Tay, LH; Harmatz, P; Vichinsky, E; Chirnomas, D; Kwiatkowski, J; ... Neufeld, EJ; + view all (2010) A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload. In: BLOOD. (pp. 853 - 854). AMER SOC HEMATOLOGY

Riley, V; Hough, R; Whelan, J; (2010) Transition: the cancer perspective. Br J Hosp Med (Lond) , 71 (6) pp. 321-325. 10.12968/hmed.2010.71.6.48441.

Roberts, CH; Mayor, NP; Madrigal, JA; Marsh, SGE; (2010) Short template amplicon and multiplex megaprimer-enabled relay (STAMMER) sequencing, a simultaneous approach to higher throughput sequence-based typing of polymorphic genes. IMMUNOGENETICS , 62 (4) pp. 253-260. 10.1007/s00251-010-0432-5.

Robinson, J; Marsh, SGE; (2010) The IMGT/HLA Database. In: Davies, MN and Ranganathan, S and Flower, DR, (eds.) Bioinformatics for Immunomics: Immunomics Reviews. (pp. 33-46). Springer: New York, USA.

Robinson, J; Marsh, SGE; (2010) IPD - the Immuno Polymorphism Database. In: Davies, MN and Ranganathan, S and Fower, DR, (eds.) Bioinformatics for Immunomics: Immunomics Reviews. (pp. 21-32). Springer: New York, USA.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Marsh, SGE; (2010) IPD--the Immuno Polymorphism Database. D863-D869. Gold open access

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Marsh, SGE; (2010) IPD-the Immuno Polymorphism Database. NUCLEIC ACIDS RESEARCH , 38 D863-D869. 10.1093/nar/gkp879.

S

Saewong, T; Ounjaijean, S; Mundee, Y; Pattanapanyasat, K; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2010) Effects of Green Tea on Iron Accumulation and Oxidative Stress in Livers of Iron-Challenged Thalassemic Mice. MED CHEM , 6 (2) 57 - 64.

Samarasinghe, S; Mancao, C; Pule, M; Nawroly, N; Karlsson, H; Brewin, J; Openshaw, P; ... Amrolia, PJ; + view all (2010) Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy. BLOOD , 115 (2) 396 - 407. 10.1182/blood-2009-08-235895.

Samuel, ER; Newton, K; Mackinnon, S; Lowdell, MW; (2010) CMV Reactive T Cells Can Be Isolated From G CSF Mobilised Peripheral Blood Apheresates. In: BLOOD. (pp. 546 - 546). AMER SOC HEMATOLOGY

Samuel, ER; Newton, K; Mackinnon, S; Lowdell, MW; (2010) CMV-Reactive T Cells Can Be Isolated From G-CSF Mobilised Peripheral Blood Apheresates. In: BLOOD. (pp. 546 - 546). AMER SOC HEMATOLOGY

Sanchez-Mazas, A; Nunes, JM; Vidan-Jeras, B; Fischer, G; Little, A-M; Bekmane, U; Buhler, S; ... Tiercy, J-M; + view all (2010) HLA-NET, an EU-funded network for research on HLA diversity. In: (Proceedings) 24th European Immunogenetics and Histocompatibility Conference/17th Annual Meeting of the Italian-Society-for-Immunogenetics-and-Transplantation-Biology. (pp. pp. 505-506). WILEY-BLACKWELL PUBLISHING, INC

Schellekens, J; Schaffer, M; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2010) Identification of a novel KIR3DL1*072 allele by sequence-based typing. TISSUE ANTIGENS , 76 (1) pp. 74-75. 10.1111/j.1399-0039.2010.01464.x.

Schure, U; Magnusson, A; Lahiri, N; Andre, R; Rabbanian, S; Lowdell, MW; Bjorkqvist, M; (2010) CELLULAR SIGNALLING OF HUMAN MONOCYTES IN HUNTINGTON'S DISEASE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 (1) A6-A6. 10.1136/jnnp.2010.222570.18.

Schure, U; Magnusson, A; Lahiri, N; Andre, R; Rabbanian, S; Lowdell, MW; Bjorkqvist, M; (2010) CELLULAR SIGNALLING OF HUMAN MONOCYTES IN HUNTINGTON'S DISEASE. In: (pp. A6-A6). BMJ PUBLISHING GROUP

Sellar, RS; Corbett, EL; D'Sa, S; Linch, DC; Ardeshna, KM; (2010) Lesson of the Week Treatment for lymph node tuberculosis. BRIT MED J , 340 , Article c63. 10.1136/bmj.c63.

Sellar, RS; Corbett, EL; D'Sa, S; Linch, DC; Ardeshna, KM; (2010) [Therapy of lymph node tuberculosis]. Praxis (Bern 1994) , 99 (17) pp. 1043-1046. 10.1024/1661-8157/a000242.

Sellar, RS; Corbett, EL; D'Sa, S; Linch, DC; Ardeshna, KM; (2010) Treatment for lymph node tuberculosis. BMJ , 340 c63-. 10.1136/bmj.c63.

Shafi, NT; Hughes, DA; Baker, R; Smith, C; Hurst, J; Mehta, A; Lipman, M; (2010) LUNG-BASED ASSESSMENT IN ANDERSON FABRY DISEASE (AFD) DEMONSTRATES DIFFERENTIAL alpha GALACTOSIDASE A ENZYME (GLA) ACTIVITY AT BLOOD AND TISSUE SITES. In: THORAX. (pp. A153 - A154). B M J PUBLISHING GROUP

Shaw, BE; (2010) First do no harm. BLOOD , 115 (24) 4978 - 4979.

Shaw, BE; Apperley, J; Russell, NH; Craddock, C; Liakopoulou, E; Potter, MN; Wynn, R; ... BSBMT, ; + view all (2010) Transplantation using BM or PBSC in adult and paediatric recipients of T-cell depleted myeloablative transplants for standard risk leukaemia results in similar outcomes. In: BONE MARROW TRANSPLANTATION. (pp. S160 - S160). NATURE PUBLISHING GROUP

Shaw, BE; Arguello, R; Garcia-Sepulveda, CA; Madrigal, JA; (2010) The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. BRIT J HAEMATOL , 150 (3) 251 - 258. 10.1111/j.1365-2141.2010.08224.x.

Shaw, BE; Ball, L; Beksac, M; Bengtsson, M; Confer, D; Diler, S; Fechter, M; ... WMDA, ; + view all (2010) Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. BONE MARROW TRANSPL , 45 (5) 832 - 838. 10.1038/bmt.2010.2.

Shaw, BE; Byrne, J; Das Gupta, E; Ethell, M; Figueroa, D; Madrigal, JA; Morgan, GJ; ... Russell, NH; + view all (2010) Results of a Prospective Clinical Trial of Pre DLI Lymphoreduction Using Oral Fludarabine In Patients with Mixed Chimerism Post Allogeneic Transplant. In: BLOOD. (pp. 556 - 556). AMER SOC HEMATOLOGY

Shaw, BE; Byrne, J; Das-Gupta, E; Ethell, M; Figueroa, D; Madrigal, JA; Morgan, GJ; ... Russell, NH; + view all (2010) Results of a Prospective Clinical Trial of Pre-DLI Lymphoreduction Using Oral Fludarabine In Patients with Mixed Chimerism Post Allogeneic Transplant. In: BLOOD. (pp. 556 - 556). AMER SOC HEMATOLOGY

Shaw, BE; Fleischhauer, K; Malkki, M; Gooley, T; Zino, E; Spellman, S; Morishima, Y; ... Madrigal, JA; + view all (2010) Permissive HLA DPB1 Mismatching Compared to a Non Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors. In: BLOOD. (pp. 105 - 106). AMER SOC HEMATOLOGY

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; ... Madrigal, JA; + view all (2010) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. LEUKEMIA , 24 (1) 58 - 65. 10.1038/leu.2009.239.

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; ... Madrigal, JA; + view all (2010) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. pp. 58-65.

Sibson, KR; Sellar, RS; Rhodes, S; Scully, M; Cohen, H; (2010) Lower doses of prothrombin complex concentrate achieve emergency reversal of warfarin. In: (Proceedings) British society for haematology annual scientific meeting.

Simpson, TR; Quezada, SA; Allison, JP; (2010) Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). CURR OPIN IMMUNOL , 22 (3) 326 - 332. 10.1016/j.coi.2010.01.001.

Sims, TL; McGee, M; Williams, RF; Myers, AL; Tracey, L; Hamner, JB; Ng, C; ... Davidoff, AM; + view all (2010) IFN-β restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation. Molecular Cancer Therapeutics , 9 (3) pp. 761-771. 10.1158/1535-7163.MCT-09-0800.

Sims, TL; McGee, M; Williams, RF; Myers, AL; Tracey, L; Hamner, JB; Ng, C; ... Davidoff, AM; + view all (2010) IFN-beta Restricts Tumor Growth and Sensitizes Alveolar Rhabdomyosarcoma to Ionizing Radiation. MOL CANCER THER , 9 (3) 761 - 771. 10.1158/1535-7163.MCT-09-0800.

Sive, JI; Buck, G; Fielding, A; Lazarus, HM; Litzow, MR; Luger, S; Marks, DI; ... Goldstone, AH; + view all (2010) Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. pp. 218-219). AMER SOC HEMATOLOGY

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; Giardina, P; ... Neufeld, EJ; + view all (2010) Changes In Health Status and Quality of Life In Adults with Thalassemia Year 1 Report of the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 652 - 653). AMER SOC HEMATOLOGY

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; Giardina, P; ... Neufeld, EJ; + view all (2010) Changes In Health Status and Quality of Life In Adults with Thalassemia: Year 1 Report of the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 652 - 653). AMER SOC HEMATOLOGY

Speyer, BE; Pizzey, AR; Ranieri, M; Joshi, R; Delhanty, JDA; Serhal, P; (2010) Fall in implantation rates following ICSI with sperm with high DNA fragmentation. HUMAN REPRODUCTION , 25 (7) pp. 1609-1618. 10.1093/humrep/deq116.

Steele, A; Prentice, A; Hoffbrand, A; Cwynarski, K; Wickremasinghe, R; (2010) PIFITHRIN mu ACTIVATES THE UNFOLDED PROTEIN RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS. In: (Proceedings) 15th Annual Meeting of the European-Hematology-Association. (pp. p. 182). FERRATA STORTI FOUNDATION Gold open access

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Hart, SM; Lowdell, MW; Samuel, ER; (2010) The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment. BLOOD , 116 (22) 4569 - 4577. 10.1182/blood-2009-09-245811.

Stengel, C; Cheung, CW; Quinn, J; Yong, K; Khwaja, A; (2010) Dual inhibition of phosphoinositide 3-kinase (PI3K) and mTOR signalling selectively induces apoptosis in multiple myeloma cells expressing the t(4;14) translocation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 20 - 20). WILEY-BLACKWELL PUBLISHING, INC

Stringaris, K; Barrett, AJ; Hills, R; Linch, DC; Gale, R; Allen, C; Garland, P; ... Apperley, JF; + view all (2010) A Distinct Signature of Natural Killer Cell MR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls. In: BLOOD. (pp. 711 - 712). AMER SOC HEMATOLOGY

Sumer, H; Jones, KL; Liu, J; Heffernan, C; Tat, PA; Upton, KR; Verma, PJ; (2010) Reprogramming of Somatic Cells After Fusion With Induced Pluripotent Stem Cells and Nuclear Transfer Embryonic Stem Cells. Stem Cells and Development , 19 (2) pp. 239-246. 10.1089/scd.2009.0142.

Sumer, H; Nicholls, C; Liu, J; Tat, PA; Liu, J-P; Verma, PJ; (2010) Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion. The International Journal of Developmental Biology , 54 (11-12) pp. 1723-1728. 10.1387/ijdb.103204hs.

T

Taher, A; Elalfy, M; El-Beshlawy, A; Zhou, D; Chan, LL; Li, CK; Lin, KH; ... Cappellini, MD; + view all (2010) EFFICACY, PATIENT SATISFACTION AND ADHERENCE TO TREATMENT WITH DEFERASIROX DOSES OF=30 MG/KG/DAY IN PREVIOUSLY CHELATED IRON-OVERLOADED PATIENTS WITH BETA-THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 709 - 709). FERRATA STORTI FOUNDATION Gold open access

Taher, A; Viprakasit, V; Porter, J; Kattamis, A; Lawniczek, T; Pereno, R; Schoenborn-Kellenberger, O; (2010) FACTORS ASSOCIATED WITH IRON ACCUMULATION IN NON-TRANSFUSION-DEPENDENT THALASSAEMIA SYNDROMES: BASELINE DATA FROM MULTICENTER INTERNATIONAL DEFERASIROX STUDY (THALASSA). In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 707 - 707). FERRATA STORTI FOUNDATION Gold open access

Tan, MH; Smith, AJ; Pawlyk, B; Xu, XY; Liu, XQ; Bainbridge, JB; Basche, M; ... Ali, RR; + view all (2010) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors (vol 18, pg 2099, 2009). HUM MOL GENET , 19 (4) 735 - 735. 10.1093/hmg/ddp540.

Tat, PA; Sumer, H; Jones, KL; Upton, K; Verma, PJ; (2010) The Efficient Generation of Induced Pluripotent Stem (iPS) Cells From Adult Mouse Adipose Tissue-Derived and Neural Stem Cells. Cell Transplantation , 19 (5) pp. 525-536. 10.3727/096368910X491374.

Taylor, C; Cohen, H; Mold, D; Jones, H; (2010) The 2009 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Thomas, AS; Garbowski, M; Ang, AL; Shah, FT; Walker, JM; Moon, JC; Pennell, DJ; (2010) A Decade Follow up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR) Significant Reduction In Patients with Cardiac Iron and In Total Mortality. In: BLOOD. (pp. 444 - 445). AMER SOC HEMATOLOGY

Thomas, AS; Garbowski, M; Ang, AL; Shah, FT; Walker, JM; Moon, JC; Pennell, DJ; (2010) A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality. In: BLOOD. (pp. 444 - 445). AMER SOC HEMATOLOGY

Thomson, G; Marthandan, N; Guidry, PA; Mack, SJ; Single, RM; Valdes, AM; Salamon, H; ... Helmberg, W; + view all (2010) Sequence feature variant type (SFVT) analysis of HLA DR-DQ amino acids in type 1 diabetes (T1D). In: (Proceedings) 24th European Immunogenetics and Histocompatibility Conference/17th Annual Meeting of the Italian-Society-for-Immunogenetics-and-Transplantation-Biology. (pp. p. 618). WILEY-BLACKWELL PUBLISHING, INC

Thomson, G; Marthandan, N; Hollenbach, JA; Mack, SJ; Erlich, HA; Single, RM; Waller, MJ; ... Helmberg, W; + view all (2010) SEQUENCE FEATURE VARIANT TYPE (SFVT) ANALYSIS OF THE HLA GENETIC ASSOCIATION IN JUVENILE IDIOPATHIC ARTHRITIS. PACIFIC SYMPOSIUM ON BIOCOMPUTING 2010 pp. 359-370.

Thomson, K; Morris, E; Milligan, D; Parker, A; Hunter, A; Cook, G; Bloor, A; ... Mackinnon, S; + view all (2010) T-cell depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma. In: BONE MARROW TRANSPLANTATION. (pp. S57 - S57). NATURE PUBLISHING GROUP

Thomson, KJ; Morris, EC; Milligan, D; Parker, AN; Hunter, AE; Cook, G; Bloor, AJC; ... Mackinnon, S; + view all (2010) T-Cell-Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma. J CLIN ONCOL , 28 (23) 3695 - 3700. 10.1200/JCO.2009.26.9100.

Titeux, M; Pendaries, V; Zanta-Boussif, MA; Décha, A; Pironon, N; Tonasso, L; Mejia, JE; ... Hovnanian, A; + view all (2010) SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther , 18 (8) pp. 1509-1518. 10.1038/mt.2010.91.

Tracey, L; Streck, CJ; Du, Z; Williams, RF; Pfeffer, LM; Nathwani, AC; Davidoff, AM; (2010) NF-kappa B activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia. LEUKEMIA , 24 (4) 806 - 812. 10.1038/leu.2010.2.

Tracey, L; Streck, CJ; Du, Z; Williams, RF; Pfeffer, LM; Nathwani, AC; Davidoff, AM; (2010) NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia. Leukemia , 24 (4) pp. 806-812. 10.1038/leu.2010.2.

V

Velica, P; Davies, NJ; Rocha, PP; Schrewe, H; Ride, JP; Bunce, CM; (2010) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers (vol 8, pg 121, 2009). MOL CANCER , 9 , Article 21. 10.1186/1476-4598-9-21. Gold open access

Velica, P; Khanim, FL; Bunce, CM; (2010) Prostaglandin D-2 inhibits C2C12 myogenesis. MOL CELL ENDOCRINOL , 319 (1-2) 71 - 78. 10.1016/j.mce.2010.01.023.

Vezzalini, M; Aletta, JM; Beghelli, S; Moratti, E; Della Peruta, M; Mafficini, A; Mojica, WD; ... Sorio, C; + view all (2010) Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues. HISTOPATHOLOGY , 57 (5) pp. 725-733. 10.1111/j.1365-2559.2010.03684.x.

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; Inusa, B; ... Coates, TD; + view all (2010) Long Term Safety and Efficacy of Deferasirox (Exjade (R)) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years. In: BLOOD. (pp. 367 - 368). AMER SOC HEMATOLOGY

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; Inusa, B; ... Coates, TD; + view all (2010) Long-Term Safety and Efficacy of Deferasirox (Exjade (R)) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years. In: BLOOD. (pp. 367 - 368). AMER SOC HEMATOLOGY

Viprakasit, V; Gattermann, N; Lee, JW; Porter, JB; Taher, A; Habr, D; Roubert, B; ... Cappellini, MD; + view all (2010) Geographical Differences In Transfusion and Iron Chelation Practices In 1558 Patients with Transfusion Dependent Anemias. In: BLOOD. (pp. 1733 - 1734). AMER SOC HEMATOLOGY

Viprakasit, V; Gattermann, N; Lee, JW; Porter, JB; Taher, A; Habr, D; Roubert, B; ... Cappellini, MD; + view all (2010) Geographical Differences In Transfusion and Iron Chelation Practices In 1558 Patients with Transfusion-Dependent Anemias. In: BLOOD. (pp. 1733 - 1734). AMER SOC HEMATOLOGY

van Walraven, SM; Nicoloso-de Faveri, G; Axdorph-Nygell, UAI; Douglas, KW; Jones, DA; Lee, SJ; Pulsipher, M; ... Clinical Working Grp, ; + view all (2010) Family donor care management: principles and recommendations. BONE MARROW TRANSPL , 45 (8) 1269 - 1273. 10.1038/bmt.2009.354.

W

Waldmeier, F; Bruin, GJ; Glaenzel, U; Hazell, K; Sechaud, R; Warrington, S; Porter, JB; (2010) Pharmacokinetics, Metabolism, and Disposition of Deferasirox in beta-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State. DRUG METAB DISPOS , 38 (5) 808 - 816. 10.1124/dmd.109.030833.

Walton, JA; Lydyard, PM; Nathwani, A; Emery, V; Akbar, A; Glennie, MJ; Porakishvili, N; (2010) Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype. BRIT J HAEMATOL , 148 (2) 274 - 284. 10.1111/j.1365-2141.2009.07964.x.

Ward, NJ; Buckley, SM; Waddington, SN; Nathwani, AC; Tuddenham, EG; Kinnon, C; Thrasher, AJ; (2010) Correction of Murine Hemophilia A Using SIN Lentiviral Vectors Expressing Enhanced Human Factor VIII cDNAs. In: HUMAN GENE THERAPY. (pp. 502 - 502). MARY ANN LIEBERT INC

Williams, RF; Myers, AL; Sims, TL; Ng, CY; Nathwani, AC; Davidoff, AM; (2010) Targeting multiple angiogenic pathways for the treatment of neuroblastoma. JOURNAL OF PEDIATRIC SURGERY , 45 (6) 1103 - 1109. 10.1016/j.jpedsurg.2010.02.073.

Williams, RF; Sims, TL; Tracey, L; Myers, AL; Ng, CYC; Poppleton, H; Nathwani, AC; (2010) Maturation of Tumor Vasculature by Interferon-beta Disrupts the Vascular Niche of Glioma Stem Cells. ANTICANCER RES , 30 (9) 3301 - 3308.

Z

Zhang, Y; Fielding, A; (2010) Mechanisms of oncolytic measles virus-induced neutrophil-mediated cytotoxicity against tumour. In: HUMAN GENE THERAPY. (pp. 1472 - 1473). MARY ANN LIEBERT INC

Zitvogel, L; Kepp, O; Senovilla, L; Menger, L; Chaput, N; Kroemer, G; (2010) Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res , 16 (12) pp. 3100-3104. 10.1158/1078-0432.CCR-09-2891.

This list was generated on Sun May 19 04:44:52 2019 BST.